Linalool (+)

Linalool (+)

SCHEMBL891312

C=C[C@](C)(O)CCC=C(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 8/20 1.00
HIF1A Q16665 4/20 0.44
EPAS1 Q99814 4/20 0.44
KMT2A Q03164 5/20 0.41
CYP3A4 P08684 5/20 0.41
MEN1 O00255 4/20 0.41
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.39
CHRNA7 P36544 1/20 0.39
STAT3 P40763 1/20 0.39
MAPT P10636 2/20 0.31
PTPN1 P18031 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
UGT1A1 P22309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Linalool SCHEMBL254425 1.00 ALOX15 (1.00) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool (+) SCHEMBL901244 1.00 ALOX15 (1.00) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL20316 1.00 ALOX15 (1.00) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL29481111 1.00 ALOX15 (1.00) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL988357 1.00 ALOX15 (1.00) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL25377128 0.98 ALOX15 (0.96) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL30540150 0.98 ALOX15 (0.96) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL28807873 0.98 ALOX15 (0.96) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL32681772 0.98 ALOX15 (0.96) ALOX15HIF1AEPAS1KMT2ACYP3A4
Linalool SCHEMBL11538181 0.98 ALOX15 (0.96) ALOX15HIF1AEPAS1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739151-A1 COMPOSITION Nicoventures Trading Limited (GB) 2026-05-13 EP claimed
US-20260002102-A1 METHODS AND SYSTEMS FOR THE RECOVERY OF POLAR AND NON-POLAR AROMA COMPOUNDS FROM A DEALCOHOLIZED BEVERAGE FLAVOLOGIC GMBH (DE) 2026-01-01 US claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
WO-2025202181-A1 TERPENOID COMPOSITIONS AND BLENDS THEREOF EVODIABIO APS (DK) 2025-10-02 WO claimed
US-20250304517-A1 STERIOISOMER-SPECIFIC CANNABIS FORMULATIONS AND ANALYSIS SCIENTIFIC HOLDINGS, LLC (US) 2025-10-02 US claimed
US-20250290102-A1 Production of terpenoid compound and the strain used by Xi'an Zhuohong New Energy Biotechnology Co., Ltd. (CN) 2025-09-18 US claimed
WO-2025074341-A1 METHODS AND SYSTEMS FOR THE RECOVERY OF POLAR AND NON-POLAR AROMA COMPOUNDS FROM A DEALCOHOLIZED BEVERAGE FLAVOLOGIC GMBH (DE) 2025-04-10 WO claimed
CN-119736218-A Production of terpenoid and strain 西安卓虹超源生物科技有限公司 2025-04-01 CN claimed
CN-119709565-A Production of terpenes method for preparing compounds 西安卓虹超源生物科技有限公司 2025-03-28 CN claimed
WO-2025060722-A1 PRODUCTION OF TERPENOID COMPOUND AND STRAIN 西安卓虹超源生物科技有限公司 2025-03-27 WO claimed
WO-2016049404-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049394-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049407-A1 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049395-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-8961958-B2 High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use BIOAVAILABILITY, INC (US) 2015-02-24 US claimed
US-20110207829-A1 CONTROL OF TERMITES, FIRE ANTS AND CARPENTER ANTS BEDOUKIAN RESEARCH, INC 2011-08-25 US claimed
US-20090060891-A1 High Concentration Self-Microemulsifying Coenzyme Q10 Preparations For Nutritional Use BIOAVAILABILTY, INC. 2009-03-05 US claimed
US-6703218-B2 GENERATION OF PREFERENTIAL ODOR COMPOUND; FOR USE IN PERFUMES HAARMAN & REIMER GMBH (DE) 2004-03-09 US claimed
US-20020086376-A1 Process for the preparation of linalool oxide or of linalool oxide-containing mixtures SYMRISE GMBH & CO. KG (DE) 2002-07-04 US claimed
EP-1205544-A2 Process for the production of linalool oxide or of linalool oxide containing mixtures HAARMANN & REIMER GMBH (DE) 2002-05-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 ALOX15 143/4885HIF1A 3715/4885EPAS1 3699/4885
US-20260002102-A1 METHODS AND SYSTEMS FOR THE RECOVERY OF POLAR AND NON-POLAR AROMA COMPOUNDS FROM A DEALCOHOLIZED BEVERAGE LIPC, ADH1C, FFAR3 ALOX15 59/4885HIF1A 4453/4885EPAS1 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.